Bank of America
ANIX icon

Bank of America’s Anixa Biosciences ANIX Stock Holding History

Bank of America’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,573
Closed -$17.4K – 5747
2025
Q4 		$17.4K Sell
5,573
-208,382
-97% -$853K ﹤0.01% 6075
2025
Q3 		$706K Buy
213,955
+3,645
+2% +$11.5K ﹤0.01% 5564
2025
Q2 		$694K Buy
210,310
+41
+0% +$117 ﹤0.01% 5522
2025
Q1 		$601K Buy
210,269
+12
+0% +$34 ﹤0.01% 5555
2024
Q4 		$488K Sell
210,257
-6,891
-3% -$21.4K ﹤0.01% 5552
2024
Q3 		$684K Buy
217,148
+234
+0.1% +$720 ﹤0.01% 5294
2024
Q2 		$479K Buy
216,914
+100,000
+86% +$284K ﹤0.01% 5370
2024
Q1 		$365K Buy
116,914
+100,000
+591% +$399K ﹤0.01% 5540
2023
Q4 		$65.6K Hold
16,914
– – ﹤0.01% 6524
2023
Q3 		$55.3K Sell
16,914
-695
-4% -$2.43K ﹤0.01% 6472
2023
Q2 		$56.3K Buy
17,609
+72
+0.4% +$277 ﹤0.01% 6418
2023
Q1 		$75.4K Hold
17,537
– – ﹤0.01% 6358
2022
Q4 		$74.5K Buy
17,537
+4,124
+31% +$19.8K ﹤0.01% 6341
2022
Q3 		$66K Buy
13,413
+9,464
+240% +$38.4K ﹤0.01% 6550
2022
Q2 		$12K Buy
3,949
+424
+12% +$1.34K ﹤0.01% 7332
2022
Q1 		$10K Sell
3,525
-1,540
-30% -$4.52K ﹤0.01% 7733
2021
Q4 		$15K Sell
5,065
-293
-5% -$1.19K ﹤0.01% 7601
2021
Q3 		$26K Buy
5,358
+5,337
+25,414% +$24.1K ﹤0.01% 7306
2021
Q2 		$0 Buy
21
+13
+163% +$55 ﹤0.01% 7724
2021
Q1 		$0 Hold
8
– – ﹤0.01% 7394
2020
Q4 		$0 Sell
8
-559
-99% -$1.41K ﹤0.01% 7080
2020
Q3 		$1K Hold
567
– – ﹤0.01% 6745
2020
Q2 		$2K Sell
567
-4,045
-88% -$8.39K ﹤0.01% 6654
2020
Q1 		$7K Buy
4,612
+604
+15% +$1.77K ﹤0.01% 6439
2019
Q4 		$13K Sell
4,008
-4,432
-53% -$16.3K ﹤0.01% 6598
2019
Q3 		$33K Buy
8,440
+4,272
+102% +$17.9K ﹤0.01% 6455
2019
Q2 		$15K Buy
4,168
+80
+2% +$338 ﹤0.01% 6632
2019
Q1 		$18K Buy
4,088
+8
+0.2% +$38 ﹤0.01% 6517
2018
Q4 		$16K Sell
4,080
-430
-10% -$1.85K ﹤0.01% 6533
2018
Q3 		$21K Buy
4,510
+430
+11% +$1.62K ﹤0.01% 6491
2018
Q2 		$12K Buy
4,080
+4,000
+5,000% +$14.8K ﹤0.01% 6617
2018
Q1 		$0 Sell
80
-1,040
-93% -$4K ﹤0.01% 7079
2017
Q4 		$3K Buy
1,120
+1,040
+1,300% +$2.7K ﹤0.01% 6797
2017
Q3 		$0 Hold
80
– – ﹤0.01% 7035
2017
Q2 		$0 Buy
+80
New +$111 ﹤0.01% 6918
2017
Q1 		– Sell
-401
Closed -$2K – 6948
2016
Q4 		$2K Sell
401
-137
-25% -$761 ﹤0.01% 6830
2016
Q3 		$2K Buy
538
+135
+33% +$450 ﹤0.01% 6797
2016
Q2 		$1K Buy
403
+3
+0.8% +$9 ﹤0.01% 6975
2016
Q1 		$1K Hold
400
– – ﹤0.01% 6846
2015
Q4 		$1K Hold
400
– – ﹤0.01% 7174
2015
Q3 		$2K Buy
+400
New +$1.86K ﹤0.01% 6950

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bank of America's ANIX Position: Q1 2026 in Review

Bank of America sold out of Anixa Biosciences (ANIX) in Q1 2026, closing a stake of 5,573 shares — an estimated $17.4K sold.

Bank of America first reported a position in ANIX in Q3 2015 and held it in 41 quarters. The position peaked at $706K in Q3 2025. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Bank of America reported no remaining Anixa Biosciences position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 5,573 Anixa Biosciences shares in Q1 2026, an estimated $17.4K.
  • Bank of America first reported a position in Anixa Biosciences in Q3 2015 and held it in 41 quarters.
  • Bank of America's Anixa Biosciences position peaked at $706K in Q3 2025.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.